![John Maraganore](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
John Maraganore
Director/Board Member at TAKEDA PHARMACEUTICAL COMPANY LIMITED
Net worth: - $ as of 29/11/2025
Profile
John M. Maraganore is a businessperson who has been the head of 5 different companies. Dr. Maraganore occupies the position of Chief Executive Officer & Director at Alnylam Pharmaceuticals, Inc. He is also on the board of Biotechnology Innovation Organization (former Chairman), Agios Pharmaceuticals, Inc. (former Chairman) and Tempero Pharmaceuticals, Inc. In his past career he held the position of Director at MacroGenics, Inc., Director at Regulus Therapeutics, Inc., Director-Market & Business Development at Biogen, Inc. Director-Market & Business Development at Biogen MA, Inc. and Director-Molecular Biology & Business Development at Biogen Idec, Inc. (North Carolina) (both are subsidiaries of Biogen, Inc.), Strategic Advisor at Longwood Fund Management LLC, Scientist at The Upjohn Co., Senior VP-Strategic Product Development at Millennium Pharmaceuticals, Inc., Scientist at ZymoGenetics, Inc. and Venture Partner at Third Rock Ventures GP LP. Dr. Maraganore received a doctorate, a graduate degree and an undergraduate degree from The University of Chicago.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 03/06/2025 | 0 ( -.--% ) | - $ | 29/11/2025 | |
Prokidney Equity LLC
 Prokidney Equity LLC Operates as a kidney centre -.--% | 10/07/2022 | 614,013 ( -.--% ) | - $ | Today |
| 24/06/2025 | 0 ( -.--% ) | - $ | 29/11/2025 | |
| 20/04/2025 | 0 ( -.--% ) | - $ | 29/11/2025 |
Latest news about John Maraganore
John Maraganore active positions
| Companies | Position | Start |
|---|---|---|
| BEAM THERAPEUTICS INC. | Director/Board Member | 04/11/2021 |
| BLACKSTONE INC. | Consultant / Advisor | 31/01/2022 |
| KYMERA THERAPEUTICS, INC. | Director/Board Member | 31/12/2021 |
| RAPPORT THERAPEUTICS, INC. | Director/Board Member | 29/02/2024 |
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Director/Board Member | 31/05/2022 |
| INSTIL BIO, INC. | Director/Board Member | 10/06/2025 |
Aitia, Inc.
 Aitia, Inc. Provides analytics solutions for the healthcare industry | Chairman | 02/11/2022 |
Atlas Venture Advisors, Inc.
 Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors invests in companies located in the United States. The firm focuses on life sciences and biotech sectors. It provides financing for early stage capital requirements. | Consultant / Advisor | 31/12/2021 |
Termeer Foundation
 Termeer Foundation The Termeer Foundation is a non-profit organization that aims to connect and empower healthcare innovators to find a cure for every patient. The company offers grants for STEM organizations and scholarships for academic and life science leaders. The organization is committed to inclusiveness and recognizes the underrepresentation of women, people with disabilities, LGBTQIA+ individuals, and Black, Brown, and Indigenous People of Color within the biopharmaceutical industry. The Termeer Foundation is based in Boston and was founded by Alan E. Walts. | Director/Board Member | - |
| ░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░ | - |
| ░░░░░ ░░░░ ░░░░░░░░░░ ░░░ | ░░░░░░░░░░ ░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
| ░░░░░░░ ░░░░ | ░░░░░░░░░░ ░ ░░░░░░░ | - |
Former positions of John Maraganore
| Companies | Position | End |
|---|---|---|
| ░░░░░░░░░ ░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░ | ░░░░░░░░░░ |
Training of John Maraganore
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 38 |
|---|---|
Biogen MA, Inc.
 Biogen MA, Inc. Develops and manufactures drugs related to immunology, neurobiology and oncology | |
The Upjohn Co.
 The Upjohn Co. Manufacturer of pharmaceuticals | |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures oncology treatment products | Health Technology |
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
ZymoGenetics, Inc.
 ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology Develops protein based drugs | Health Technology |
ARCH Venture Partners LLC
 ARCH Venture Partners LLC Investment ManagersFinance ARCH Venture Partners invests in disruptive science companies located in the United States. The firm target companies operating in the fields of biotechnology and technology sectors. It provides financing for early stage capital requirements with a minimum investment size of $0.05 million and also makes co-investments. | Finance |
Taligen Therapeutics, Inc.
 Taligen Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and develops inflammatory disease pharamaceutical products | Health Technology |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Commercial Services |
Aitia, Inc.
Aitia, Inc. Provides analytics solutions for the healthcare industry | |
Agios Pharmaceuticals, Inc.
 Agios Pharmaceuticals, Inc. Discovers and develops therapeutics | |
Takeda Pharmaceutical Co., Ltd.
 Takeda Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Engages in the research, development, manufacturing and marketing of pharmaceutical products | Health Technology |
MacroGenics, Inc.
 MacroGenics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes antibody-based therapeutics for the treatment of cancer | Health Technology |
bluebird bio, Inc.
 bluebird bio, Inc. BiotechnologyHealth Technology Develops next generation products based on the transformative potential of gene therapy | Health Technology |
Atlas Venture Advisors, Inc.
Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors invests in companies located in the United States. The firm focuses on life sciences and biotech sectors. It provides financing for early stage capital requirements. | Finance |
Alnylam Pharmaceuticals, Inc.
 Alnylam Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics based on RNA interference | Health Technology |
The University of Chicago
 The University of Chicago Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Biogen Idec, Inc. (North Carolina)
 Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Blackstone, Inc.
 Blackstone, Inc. Investment ManagersFinance Provides investment and fund management services | Finance |
Third Rock Ventures GP LP | |
Regulus Therapeutics, Inc.
 Regulus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that engages in discovering and developing of drugs | Health Technology |
Molecular Biology Resources, Inc.
 Molecular Biology Resources, Inc. Chemicals: Major DiversifiedProcess Industries Manufactures bio-chemicals | Process Industries |
Longwood Fund Management LLC
 Longwood Fund Management LLC Investment ManagersFinance Longwood Fund invests in companies located in the United States. The firm focuses on the healthcare sector. It participates in early stage capital transactions. | Finance |
Omega Fund Management LLC
 Omega Fund Management LLC Omega Fund Management invests in private and public companies located in the US and Europe. The firm focuses on sectors such as biotechnology, life sciences, healthcare and medical devices. It provides financing for seed, early, mid and later stage capital requirements. It makes direct secondary investments along with follow-on investments. | |
Tempero Pharmaceuticals, Inc.
 Tempero Pharmaceuticals, Inc. Develop next-generation therapies that selectively suppress Th17-cells and enhance specialized Treg cells | |
Kymera Therapeutics, Inc.
 Kymera Therapeutics, Inc. Operates as a biotechnology company that develops medicines for health problems | |
Beam Therapeutics, Inc.
 Beam Therapeutics, Inc. Develops and operates software platform for genetic medicines | |
Instil Bio, Inc.
 Instil Bio, Inc. Develops tumour infiltrating lymphocytes for the treatment of cancer | |
Ariadne Labs
 Ariadne Labs Provides hospital and healthcare services | |
Hemab ApS
 Hemab ApS Develops antibodies for the treatment of rare bleeding disorders | |
Termeer Foundation
Termeer Foundation The Termeer Foundation is a non-profit organization that aims to connect and empower healthcare innovators to find a cure for every patient. The company offers grants for STEM organizations and scholarships for academic and life science leaders. The organization is committed to inclusiveness and recognizes the underrepresentation of women, people with disabilities, LGBTQIA+ individuals, and Black, Brown, and Indigenous People of Color within the biopharmaceutical industry. The Termeer Foundation is based in Boston and was founded by Alan E. Walts. | |
Versanis Bio, Inc.
 Versanis Bio, Inc. Operates as a clinical-stage biopharmaceutical company | |
Nucleate Bio, Inc. | |
Mahzi Therapeutics, Inc.
 Mahzi Therapeutics, Inc. Provides healthcare and biotechnology services | |
Aerium Therapeutics, Inc.
 Aerium Therapeutics, Inc. Engages in discovery & development of antibodies and small molecule antivirals against SARS-CoV-2 and other epidemic & pandemic threats | |
ProKidney Corp.
 ProKidney Corp. Operates as a clinical-stage biotechnology company | |
Orbital Therapeutics, Inc.
 Orbital Therapeutics, Inc. Operates as a biotechnology company that develops RNA-based medicines | |
Transcend Therapeutics
 Transcend Therapeutics Operates as a clinical-stage, neuroscience-focused company that develops rapid-acting treatments for neuropsychiatric diseases | |
Rapport Therapeutics, Inc.
 Rapport Therapeutics, Inc. Operates as an clinical-stage biotechnology company that engages in discovery and development of medicines for neurological disorder |
- Stock Market
- Insiders
- John Maraganore
